Dianthus Therapeutics, Inc. /DE/ Quarterly Operating Lease, Liability in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Operating Lease, Liability history and growth rate from Q1 2022 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Operating Lease, Liability for the quarter ending September 30, 2024 was $311K, a 53.6% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $311K -$359K -53.6% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $407K Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $497K Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $585K -$203K -25.8% Dec 31, 2023 10-K 2024-03-21
Q3 2023 $670K -$30.1M -97.8% Sep 30, 2023 10-Q 2023-11-09
Q4 2022 $788K Dec 31, 2022 8-K 2023-12-21
Q3 2022 $30.8M Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $31.6M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $32.4M Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.